Skip to main content

Nexlizet Side Effects

Generic name: bempedoic acid/ezetimibe

Medically reviewed by Philip Thornton, DipPharm. Last updated on Jul 11, 2023.

Note: This document provides detailed information about Nexlizet Side Effects associated with bempedoic acid/ezetimibe. Some dosage forms listed on this page may not apply specifically to the brand name Nexlizet.

Applies to bempedoic acid/ezetimibe: oral tablet.

Serious side effects of Nexlizet

Along with its needed effects, bempedoic acid/ezetimibe may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking bempedoic acid/ezetimibe:

Less common side effects

  • ankle, knee, or great toe joint pain
  • arm, back, or leg pain
  • bloody urine
  • body aches or pain
  • chills
  • cough
  • cough producing mucus
  • difficulty breathing
  • difficulty in moving
  • difficulty urinating
  • dizziness
  • ear congestion
  • fainting
  • fast or irregular heartbeat
  • fever
  • frequent urination
  • headache
  • joint pain, stiffness, or swelling
  • loss of voice
  • lower back, side, or stomach pain
  • muscle pain, spasm, or stiffness
  • pain or tenderness around the eyes and cheekbones
  • pale skin
  • runny or stuffy nose
  • sneezing
  • sore throat
  • swelling of the feet or lower legs
  • tightness in the chest
  • troubled breathing with exertion
  • unusual bleeding or bruising
  • unusual tiredness or weakness

Rare side effects

  • bone pain

Incidence not known

  • black, tarry stools
  • bleeding gums
  • blistering, peeling, or loosening of the skin
  • bloating
  • chills
  • constipation
  • dark urine
  • diarrhea
  • difficulty swallowing
  • gaseous stomach pain
  • hives, itching, skin rash
  • indigestion
  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals
  • light-colored stools
  • loss of appetite
  • muscular tenderness, wasting, or weakness
  • pains in the stomach, side, or abdomen, possibly radiating to the back
  • pinpoint red spots on the skin
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • recurrent fever
  • red, irritated eyes
  • severe nausea or vomiting
  • sores, ulcers, or white spots in the mouth or on the lips
  • stomach fullness
  • upper right stomach pain
  • yellow eyes or skin
  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • discouragement
  • feeling sad or empty
  • irritability
  • loss of interest or pleasure
  • trouble concentrating
  • trouble sleeping

Check with your doctor immediately if any of the following side effects occur while taking bempedoic acid/ezetimibe:

For healthcare professionals

Applies to bempedoic acid/ezetimibe: oral tablet.

General adverse events

The most commonly reported adverse reactions have included upper respiratory tract infection, muscle spasms, hyperuricemia, back pain, abdominal pain or discomfort, bronchitis, pain in extremity, anemia, elevated liver enzymes, diarrhea, arthralgia, sinusitis, fatigue, and influenza[Ref]

Hematologic

Bempedoic Acid:

Ezetimibe:

Approximately 10.1% of patients had an increase in platelet count of 100x10(9)/L or more on 1 or more occasion of receiving bempedoic acid compared to 4.7% receiving placebo. Platelet count elevations appeared to be asymptomatic as they did not result in an increased risk of thromboembolic events or require medical intervention.

Metabolic

Bempedoic Acid:

Gout occurred in 1.5% of patients receiving this drug compared to 0% of placebo-treated patients.

Respiratory

Bempedoic Acid:

Ezetimibe:

Musculoskeletal

Bempedoic Acid:

Ezetimibe

Hepatic

Bempedoic Acid:

Ezetimibe:

Gastrointestinal

Bempedoic acid-ezetimibe:

Bempedoic Acid:

Ezetimibe:

Genitourinary

Bempedoic acid-ezetimibe:

Bempedoic Acid:

Benign prostatic hyperplasia or prostatomegaly was reported in 1.3% of patients receiving bempedoic acid versus 0.1% in placebo patients.

Immunologic

Bempedoic acid-ezetimibe:

Hypersensitivity

Ezetimibe:

Psychiatric

Ezetimibe:

Cardiovascular

Bempedoic Acid:

Atrial fibrillation was reported in 1.7% of patients receiving bempedoic acid compared with 1.1% of placebo-treated patients.

Dermatologic

Bempedoic Acid:

Ezetimibe:

Nervous system

Ezetimibe:

Other

Bempedoic acid-ezetimibe:

Ezetimibe:

Renal

Bempedoic Acid:

References

1. (2020) "Product Information. Nexlizet (bempedoic acid-ezetimibe)." Esperion Therapeutics

Frequently asked questions

Further information

Nexlizet side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.